Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the September 3, 2014, Federal Register, FDA issued a final order classifying early growth response 1 ("EGR1") gene fluorescence in-situ hybridization ("FISH") test system for specimen characterization into class II (special controls).
United StatesFood, Drugs, Healthcare, Life Sciences
within Strategy, Media, Telecoms, IT and Entertainment topic(s)
In the September 3, 2014, Federal Register,
FDA issued a final order classifying early growth response 1
("EGR1") gene fluorescence in-situ hybridization
("FISH") test system for specimen characterization into
class II (special controls). Effective October 3,
2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
